Fibrinogen Nový Jičín and Praha II: Cases of hereditary Aα 16 Arg → Cys and Aα 16 Arg → His dysfibrinogenemia

Thrombosis Research

Volumn 121, Issue 1, 2007, Pages 75-84

  Kotlín, Roman ^a   Chytilová, Martina ^a   Suttnar, Jiří ^a   Riedel, Tomáš ^a   Salaj, Peter ^a   Blatný, Jan ^b   Šantrůček, Jiří ^c   Klener, Pavel ^a   Dyr, Jan E ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

Dysfibrinogenemia; Fibrinogen; Fibrinopeptide A

Indexed keywords

ARGININE; BATROXOBIN; CYSTEINE; FIBRINOGEN; FIBRINOGEN NOVY JICIN; FIBRINOGEN PRAHA II; FIBRINOPEPTIDE; GENOMIC DNA; HISTIDINE; MUTANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING TEST; CASE REPORT; CONTROLLED STUDY; CZECH REPUBLIC; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; DYSFIBRINOGENEMIA; FEMALE; FIBRIN CLOT; FIBRIN POLYMERIZATION; GENE MUTATION; GENETIC IDENTIFICATION; HETEROZYGOTE DETECTION; HUMAN; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SCHOOL CHILD; THROMBIN TIME;

ADULT; AFIBRINOGENEMIA; BLOOD COAGULATION TESTS; CHILD; CZECH REPUBLIC; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FIBRIN; FIBRINOGENS, ABNORMAL; HEMORRHAGE; HUMANS; KINETICS; MALE; MUTATION, MISSENSE;

EID: 35649001488     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.02.011     Document Type: Article

References (23)

1. Henschen A.H., and McDonagh J. Fibrinogen, fibrin and factor XIII. In: Zwaal R.F.A., and Hemker H.C. (Eds). Blood coagulation (1986), Elsevier Science Publishers, Amsterdam 171-241
2. Olexa S.A., and Budzynski A.Z. Localization of a fibrin polymerization site. J Biol Chem 256 (1981) 3544-3549
3. http://www.geht.org/fr/pages/pratiqueBase_UK_B.html, accessed 23. 7. 2005.
4. 16 → Cys): Biochemical and physiologic characterization. Blood 78 (1991) 1744-1752
5. Bogli C., Hofer A., Baudo F., Redaelli R., and Furlan M. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg-His). Haemostasis 22 (1992) 7-11
6. Furlan M., Leupin L., Biasiutti D.F., and Lämmle B. Fibrinogen Bern III: ein weiterer Fall der hereditären Fibrinogenvariante mit Substitution Aα 16 Arg → Cys. Schweiz Med Wochenschr 121 (1991) 1068-1071
7. Clauss A. Gerinnungsphysiologische Schnell-methode zur Bestimmung des Fibrinogens. Acta Haematol 17 (1957) 237-246
8. Brennan S.O., Hammonds B., and George P.M. Aberrant hepatic processing causes removal of activation peptide and primary polymerization site from fibrinogen Canterbury (Aα Val → Asp). J Clin Invest 96 (1995) 2854-2858
9. Laemmli U.K. Claevage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
10. Suttnar J., Dyr J.E., Fořtová H., and Pristach J. Determination of fibrinopeptides by high performance liquid chromatography. Biochem Clin Bohemoslov 18 (1989) 17-25
11. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal Chem 68 (1996) 850-858
12. Reber P., Furlan M., Beck E.A., Finazzi G., Buelli M., and Barbui T. Fibrinogen Bergamo I (Aα16Arg →Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxyamidomethylation of cysteine residues. Thromb Haemost 54 (1985) 390-393
13. Loreth R.M., Meyer M., and Albert F.W. Fibrinogen Kaiserslautern III: a new case of congenital dysfibrinogenemia with Aα 16 Arg → Cys substitution. Haemostasis 31 (2001) 12-7
14. Garbis S., Lubec G., and Fountoulakis M. Limitations of current proteomics technologies. J Chromatogr A 1077 (2005) 1-18
15. Lane D.A., Ireland H., Thompson E., Frost T.J., and Cuddigan B. Two more fibrinogens (London III and Sydney) with impaired fibrinopeptide release. Thromb Res 28 (1982) 821-824
16. Stucki B., Zenhäusern R., Biedermann B., Baudo F., Redaelli R., Lämmle B., et al. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aα-chain. Blood Coagul Fibrinolysis 10 (1999) 93-99
17. Bolliger - Stücki B., Lord S.T., and Furlan M. Fibriongen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aα R16C and γ G165R. Blood 98 (2001) 351-357
18. Pechik I., Yakovlev S., Mosesson M.W., Gilliland G.L., and Medved L. Structural basis of sequential cleavage of fibrinopeptides upon fibrin assembly. Biochemistry 45 (2006) 3588-3597
19. Blombäck B., Hessel B., Hogg D., and Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 275 (1978) 501-505
20. Lewis S.D., Shields P.P., and Shafer J.A. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. J Biol Chem 260 (1985) 10192-10199
21. Soria J., Soria C., Samama M., Poirot E., and Kling C. Fibrinogen Troyes-Fibrinogen Metz. Two cases of congenital dysfibrinogenemia. Thromb Diath Haemorrh 27 (1972) 619-633
22. Huang S., Mulvihill E.R., Farrell D.H., Chung D.W., and Davie E.W. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in assembly. J Biol Chem 268 (1993) 8919-8926
23. Mathonnet F., Peltier J.Y., Roda L., de Raucourt E., D'Hailly F., Tetegan M., et al. Three new cases of dysfibrinogenemia Poissy III, Saint-Germain I and Tahiti. Thromb Res 103 (2001) 201-207